SULINDAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulindac, and when can generic versions of Sulindac launch?
Sulindac is a drug marketed by Ani Pharms, Chartwell Rx, Epic Pharma, Epic Pharma Llc, Rising, Sun Pharm Industries, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulindac
A generic version of SULINDAC was approved as sulindac by WATSON LABS on April 3rd, 1990.
Summary for SULINDAC
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 32 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SULINDAC |
| Drug Sales Revenues: | Drug sales revenues for SULINDAC |
| DailyMed Link: | SULINDAC at DailyMed |
Recent Clinical Trials for SULINDAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Healx Limited | Phase 2 |
| Memorial Sloan Kettering Cancer Center | Phase 2 |
| Johns Hopkins University | Phase 2 |
Pharmacology for SULINDAC
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for SULINDAC
Anatomical Therapeutic Chemical (ATC) Classes for SULINDAC
US Patents and Regulatory Information for SULINDAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | SULINDAC | sulindac | TABLET;ORAL | 072973-002 | Feb 28, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-002 | Sep 6, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chartwell Rx | SULINDAC | sulindac | TABLET;ORAL | 072713-001 | Aug 30, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Industries | SULINDAC | sulindac | TABLET;ORAL | 072051-001 | Apr 17, 1991 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-001 | Sep 6, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
